Prevalence of ventilator-associated events and antibiogram of bacterial isolates of ventilator-associated pneumonia in a tertiary care hospital of Uttarakhand
Background and Objectives: Despite progress in diagnosing and managing ventilator-associated pneumonia (VAP), ongoing monitoring of ventilator-associated events (VAE) is crucial due to VAP's persistent prominence as the primary cause of Hospital-Acquired Infection (HAI) among Intensive Care unit patients. This study was done to illuminate the prevalence of VAE and antibiogram of bacterial isolates of VAP in a tertiary care hospital of Uttarakhand.
Materials and Methods: This cross-sectional study focused on ICU patients. Adult patients ventilated for > 2 days were monitored daily, with VAE data analyzed using Center of Disease Control & Prevention (CDC) criteria. Specimens were sent to the Microbiology Department and cultured on Blood agar and MacConkey agar. Identification and antimicrobial profiles of isolates were determined using Vitek-2 Compact.
Results: 1220 ventilated individuals were assessed in total. VAE was diagnosed in 6.4% (78/1220) of the patients, the same later developed ventilator associated condition (VAC), 74 developed the infection-related VAC (IVAC), and 60 developed the possible/probable VAP (PVAP) among the 78 VAE cases. Klebsiella pneumoniae (35%), Acinetobacter baumannii (33%), and Pseudomonas aeruginosa (16%) were the most common isolated organisms. Colistin (57%) was the most effective against Klebsiella pneumoniae, followed by amikacin (28.5%) and trimethoprim+sulfamethoxazole (24%). Pseudomonas aeruginosa was most susceptible to imipenem (70%), meropenem, cefoperazone+sulbactam, and colistin (60%). Acinetobacter baumannii was most susceptible to colistin (85%), tigecycline (65%), and trimethoprim+sulfamethoxazole (25%).
Conclusion: The most common cause of HAI is VAP. The purpose of this study is to determine the importance of starting suitable antibiotics early for prognosis and the difficulty of diagnosing VAP.
2. Kalanuria AA, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care 2014; 18: 208.
3. Zolfaghari PS, Wyncoll DL. The tracheal tube: gateway to ventilator-associated pneumonia. Crit Care 2011; 15: 310.
4. Klompas M. Complications of mechanical ventilation--the CDC’s new surveillance paradigm. N Engl J Med 2013; 368: 1472-1475.
5. Klompas M. Ventilator-associated events 5 years later. Respir Care 2017; 62: 1501-1503.
6. Fan Y, Gao F, Wu Y, Zhang J, Zhu M, Xiong L. Does ventilator associated event surveillance detect ventilator associated pneumonia in intensive care units? A systematic review and meta analysis. Crit Care 2016; 20: 338.
7. Zaragoza R, Vidal-Cortés P, Aguilar G, Borges M, Diaz E, Ferrer R, et al. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care 2020; 24: 383.
8. Sharma A, Das M, Mishra B, Thakur A, Loomba PS. Ventilator-associated events: Incidence and mortality in intensive care unit of a superspecialty hospital of North India. Int J Health Allied Sci 2020; 9: 62-66.
9. Thomas A, Jitendranath A, Vishwamohanan I, Bhai G, Sarika. Incidence of ventilator associated events among intubated patients in neurosurgery ICU of a tertiary health centre in India. Indian J Microbiol Res 2019; 6: 150-152.
10. Vaisakh G, Sheela Pavithran, Sigimol KM, Sruthimol VS. Incidence, risk factors and measures to prevent Ventilator associated Events (VAE) among mechanical ventilated patients in selected ICU’s of a tertiary care hospital, Kerala, India. Int J Nurs Educ Res 2016; 4: 474-480.
11. Goel V, Hogade SA, Karadesai S. Ventilator associated pneumonia in a medical intensive care unit: Microbial aetiology, susceptibility patterns of isolated microorganisms and outcome. Indian J Anaesth 2012; 56: 558-562.
12. Joseph NM, Sistla S, Dutta TK, Badhe AS, Rasitha D, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens. J Infect Dev Ctries 2010; 4: 218-225.
13. Jahoor S, Tripathi M, Mittal M, Singh R, Mittal G, Aggarwal RK. Sociodemographic, clinical and bacteriological study of Ventilator associated Pneumonia (VAP) in a tertiary care Hospital of Uttarakhand, India. Int J Recent Sci Res 2021; 12: 40735-40738.
14. Agarwal S, Barnali K, Kishore N, Khanduri S, Singh M. Colistin resistance in organisms causing ventilator-associated pneumonia- Are we going into pre-antibiotic era? Crit Care Shock 2018; 21: 78-85.
15. Holden VI, Breen P, Houle S, Dozois CM, Bachman MA. Klebsiella pneumoniae siderophores induce inflammation, bacterial dissemination, and HIF-1α stabilization during pneumonia. mBio 2016; 7(5): e01397-16.
16. Holden VI, Bachman MA. Diverging roles of bacterial siderophores during infection. Metallomics 2015; 7: 986-995.
17. Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control 2008; 36(4 Suppl): S93-100.
18. Almomani BA, McCullough A, Gharaibeh R, Samrah S, Mahesneh F. Incidence and predictors of 14-day mortality in multidrug-resistant Acinetobacter baumannii in ventilator-associated pneumonia. J Infect Dev Ctries 2015; 9: 1323-1330.
19. Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison JM, Carson S, et al. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun 2010; 78: 1952-1962.
20. Alp E, Voss A. Ventilator associated pneumonia and infection control. Ann Clin Microbiol Antimicrob 2006; 5: 7.
21. Mallick UK, Faruq MO, Ahsan AA, Fatema K, Ahmed F, Asaduzzaman M, et al. Spectrum of early onset and late onset ventilator associated Pneumonia (VAP) in a tertiary care Hospital of Bangladesh: A prospective cohort study. Bangladesh Crit Care J 2015; 3: 9-13.
22. Patro S, Sarangi G, Das P, Mahapatra A, Mohapatra D, Paty BP, et al. Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital. Indian J Pathol Microbiol 2018; 61: 375-379.
23. Dey A, Bairy I. Incidence of multidrug-resistant organisms causing ventilator- associated pneumonia in tertiary care hospital: A nine months prospective study. Ann Thorac Med 2007; 2: 52-57.
|Issue||Vol 15 No 6 (2023)|
|Ventilator; Klebsiella pneumonia; Acinetobacter baumannii; Pseudomonas aeruginosa|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|